Clinical trials
Pleural Effusion Disorder clinical trials
Below are recruiting pleural effusion disorder clinical trials, each written for real people, not researchers. We’re tracking 12 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06734481Recruiting
Baking soda lung wash for complicated pleural effusion
This trial tests if washing the lung lining with a baking soda solution safely helps clear complicated fluid build-up. It may reduce infection and improve drainage.
Ningbo, ZhejiangAges 18–80 - NCT05543330RecruitingPhase 1/Phase 2
M701 for lung cancer with pleural effusion
This trial tests a new drug called M701 for people with non-small cell lung cancer that has spread to the lining of the lung, causing fluid buildup (pleural effusion). It aims to see if M701 can help control the fluid and improve symptoms.
Hangzhou, ZhejiangAges 18–75 - NCT06713382RecruitingPhase 2
Saline rinse for trapped lung infections
This trial tests if adding a simple saltwater rinse to standard chest tube drainage helps clear stubborn lung infections. It might be an option if you have an infected fluid pocket in your chest that isn't draining well.
Boston, MassachusettsAges 18 years+ - NCT07332858RecruitingPhase 1/Phase 2
Study of an experimental drug for lung cancer with fluid in the chest
This trial tests a new drug given directly into the chest cavity to treat fluid buildup caused by non-small cell lung cancer. It may help ease breathing problems and control the fluid.
Beijing, Beijing MunicipalityAges 18–75 - NCT06727578Recruiting
Pleural irrigation with a new device
This trial tests a new device to wash out fluid that stays in the chest after a chest tube is placed. It might help people who cannot receive standard medication to break up this fluid within the first day after their chest tube is inserted.
Boston, MassachusettsAges 18 years+ - NCT07211529Recruiting
Nerve block during chest surgery to reduce complications
This trial tests whether a numbing injection near the spine (paravertebral block) given during keyhole chest surgery can lower the risk of problems after surgery. It might help patients recover more comfortably.
Wuhan, HubeiAges 18–80 - NCT06983366Recruiting
Lung sliding index for diagnosing lung conditions
This study uses an ultrasound-based measurement called the Lung Sliding Index to help tell different lung diseases apart. Researchers want to see if it can be a useful and simple tool for doctors.
AsyutAges 18 years+ - NCT06538376Recruiting
New portable chest X-ray for ICU patients
This study tests a new portable chest X-ray that can be used in the ICU to check for problems like fluid in the lungs, trouble breathing, or swallowing issues. It is designed to help doctors see these problems more easily without moving you to the radiology department.
Boston, MassachusettsAges 18 years+ - NCT02092155Enrolling by invitation
Testing fluid biomarkers from a chest drain in pleural effusion
This trial studies specific markers (biomarkers) found in fluid from a chest drain to better understand pleural effusions (fluid around the lungs), especially when fluid keeps coming back after treatment. You may be helped by contributing to research that could improve how these effusions are diagnosed and managed.
Baltimore, MarylandAges 18–99 - NCT06247800Recruiting
Virtual reality to help during chest drain placement
This trial tests whether using a virtual reality (VR) headset during a chest drain procedure can help you feel less anxious or uncomfortable. The VR shows calming scenes to distract you while the doctor inserts a small tube to drain fluid or air from around your lung.
Kuala Lumpur, Kuala LumpurAges Any age - NCT06958848Recruiting
Comparing two chest tube sizes after minimally invasive lung cancer surgery
This trial compares two sizes of chest tubes (16F and 24F) placed after minimally invasive lung cancer surgery. The goal is to see which size leads to better recovery and less pain, while still draining fluid and air effectively.
BaselAges 18 years+ - NCT05477927RecruitingPhase 1
CAR-T therapy for cancers spread to lining of lungs, belly, or brain
This trial tests an experimental CAR-T cell treatment that targets proteins on cancer cells that have spread to the lining of the lungs, belly, or brain. It may help people whose cancer has not responded to standard treatments.
Chengdu, SichuanAges 18–80
Hear when a new Pleural Effusion Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for pleural effusion disorder?
- Yes. Clin2 currently lists 12 recruiting pleural effusion disorder studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a pleural effusion disorder trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a pleural effusion disorder trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.